Skip to main content
. 2015 May 28;107(8):djv132. doi: 10.1093/jnci/djv132

Table 1.

Serine hydrolase signature associated with pancreatic cancer cell lines

Gene* Total cell lysate Media Cell surface
Mean MS2# P Mean MS2# P Mean MS2# P
Pancreatic cancer Other cancers Fold change Pancreatic cancer Other cancers Fold change Pancreatic cancer Other cancers Fold change
CES2 10.3 1.4 7.2 <.001 12.7 0.7 17.2 <.001 6.4 0.1 57.9 <.001
DPP4 11.2 1.4 8.2 .02 34.7 9.7 3.6 .04 39.6 34.8 1.1 .16
LIPA 9.0 1.3 6.9 <.001 32.7 17.6 1.9 .006 3.7 0.2 17.3 <.001
ACOT1 2.3 1.0 2.3 .79 0.0 0.0 - - 3.4 0.3 11.6 .001
KLK6 7.1 0.9 8.3 <.001 209.1 46.0 4.6 .14 8.3 1.2 6.8 .004
KLK10 2.7 0.1 19.0 <.001 79.8 4.9 16.4 <.001 8.9 1.0 8.9 <.001
KLK11 1.0 0.0 - - 20.6 2.5 8.1 <.001 3.1 0.0 100.6 .002
TMPRSS4 0.4 0.1 3.3 .007 4.9 0.0 183.6 <.001 16.9 2.1 8.1 .006

* Mean MS2 counts (MS2#) for eight serine hydrolases with statistically significantly elevated protein expression in pancreatic cancer cell lines compared with other cancer type cell lines.

P values were calculated by two-sided Mann-Whitney t test.